lose to 75% of all approved antibiotics have their origin in nature, highlighting the importance of natural products for drug development 1 . However, identifying new lead molecules from this pool, preferably with novel modes of action, is becoming increasingly difficult [2] [3] [4][5] . The further development of existing molecules by chemical diversification, another well-established strategy 6 , delivers only limited structural novelty. More recently, biological diversification of enzymatically produced natural products (such as non-ribosomal peptides or polyketides) has been introduced. This strategy relies on the recombination of the involved enzyme clusters and has delivered promising leads 7,8 . However, the lack of insight into how to generate sufficient modularity for efficient enzyme shuffling and restricted experimental throughput to explore large combinatorial spaces limit the impact on drug development 9,10 . In practical terms, molecular diversification in bioengineering approaches becomes much easier if the antimicrobial molecule is a gene product itself rather than the catalytic result of several gene products whose engineering has to be carefully coordinated. One such example of a gene-encoded natural product is the diverse group of ribosomally produced and post-translationally modified peptides (RiPPs)
. The further development of existing molecules by chemical diversification, another well-established strategy 6 , delivers only limited structural novelty. More recently, biological diversification of enzymatically produced natural products (such as non-ribosomal peptides or polyketides) has been introduced. This strategy relies on the recombination of the involved enzyme clusters and has delivered promising leads 7, 8 . However, the lack of insight into how to generate sufficient modularity for efficient enzyme shuffling and restricted experimental throughput to explore large combinatorial spaces limit the impact on drug development 9, 10 . In practical terms, molecular diversification in bioengineering approaches becomes much easier if the antimicrobial molecule is a gene product itself rather than the catalytic result of several gene products whose engineering has to be carefully coordinated. One such example of a gene-encoded natural product is the diverse group of ribosomally produced and post-translationally modified peptides (RiPPs) 11 . Here, application of the well-developed methods of DNA synthesis and modification allow direct synthesis of highly diverse peptides, which are then further modified with the functionally important post-translational modification (PTM) machinery. Among RiPPs, the class of antimicrobial lanthipeptides (that is, lantibiotics) represents a rich source for promising leads against Gram-positive bacteria. The best-known representative, nisin, already has a long history as a food preservation agent and others have recently entered into clinical development for infectious diseases 12, 13 . Lantibiotics carry ring-forming amino acids (lanthionine and methyllanthionine) that result in small peptide stretches that are considerably restricted in their rotational degree of freedom ( Fig. 1a) and are introduced by an often promiscuous PTM machinery ( Supplementary Fig. 1 ), suggesting the possibility for diversifying the peptide backbone, while still enabling modifications [14] [15] [16] [17] [18] [19] . Lantibiotics commonly bind to the bacterial cell wall precursor lipid II, inhibiting cell wall formation and often also inducing pore formation in the cytoplasmic membrane of their target cells 20 . They feature a similar blueprint encompassing the location of functional elements (lipid II-binding and membrane-piercing) as well as the organization of the thioether rings inside the peptide backbone (Fig. 1a) . However, the ring structures themselves vary considerably in size and primary structure over different peptides and the peptides display highly different degrees of activity toward target strains 20 . This diversity raises the intriguing opportunity of largescale molecular shuffling to obtain novel functionality based on modules broadly organized along ring structures and other functional segments (Fig. 1b) .
To overcome the otherwise prohibitive issue of sorting through large numbers of peptide variants, we miniaturized Fleming's inhibition zone assay 21 by evaluating the result of coculturing RiPP producers and a sensor strain on the nanoliter scale ('nanoFleming') in nanoliter reactors (nLRs) and in a high-throughput manner [22] [23] [24] [25] . Here, we present the results of shuffling 33 lantibiotic peptide modules, both naturally occurring and synthetic, yielding a library of 6,000 putatively active structures. Screening of the library with the nanoFleming platform followed by detailed characterization resulted in a set of 11 antimicrobial lanthipeptides that showed improved antimicrobial activity over wild-type peptides or were able to bypass resistance mechanisms.
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NaTure ChemiCal BiOlOgy haloduracin). The peptides were modularized according to rotationally restricted regions consisting of one single or two interwoven thioether rings and flexible, interconnecting ('hinge') regions. For nisin, we identified five modules (binding modules B1 and B2 involved in lipid II-binding and pore modules P1 to P3 involved in pore formation, Fig. 1a ), extracted a further 23 modules from the remaining 11 lantibiotics and allocated those to positions B1 to P3 (Fig. 1b) . The set was completed with non-natural interconnecting hinge modules (P2) of different lengths and charges to increase the likelihood for activities against different target strains 26 and a placeholder at P1 to represent natural lantibiotics missing this module (for example, gallidermin). Finally, we limited B1 to modules from nisin and gallidermin, as this module is critical for PTM by the nisin biosynthetic machinery (vide infra) 17 . Next, we generated new-tonature peptides by randomly combining one module of each of the five groups, employing chemical synthesis of the peptide-encoding DNA and a split-and-mix approach to implement modular recombination ( Supplementary Fig. 2 ). PTM and export of lantibiotics are dependent on an N terminal leader peptide; therefore the resulting DNA library of 6,000 combinatorial variants was fused to the leader peptide of nisin and overexpressed in a Lactococcus lactis strain also producing the nisin PTM machinery NisBTC (that is, including the nisin export function NisT but excluding the protease NisP required for peptide activation by cleavage of the leader peptide) 19 (Fig. 1c) .
Development of an inhibition assay at nanoliter scale. To enable rapid bioactivity assessment of the library peptides, we developed the nanoFleming high-throughput platform for antibiotic screening. We used small alginate hydrogel compartments (500 μm diameter, volume 65 nl, hence nLRs) for bacterial growth, peptide production and bioactivity testing. In a typical experiment, on average 0.3 library cells were encapsulated per nLR together with 150 cells of the sensor strain Micrococcus flavus. The nLRs were soaked in growth medium containing the soluble form of the protease NisP (NisP sol ) 27 required for the activation of secreted peptides ( Supplementary Fig. 3 ). Incubation, conducted in a hydrophobic phase to prevent cross-talk between nLRs, allowed for the growth of library and sensor cells and peptide production. After incubation and recovery from the hydrophobic phase, the nLR-embedded biomass was stained with the fluorescent dye SYTO 9 and nLRs with no or only very little biomass, indicating effective prevention of sensor strain growth, were isolated ( Fig. 2a and Supplementary  Fig. 4) . To validate the assay, we first compared the inhibition of nLR-embedded sensors in the presence and absence of colocalized A fictitious P1 module (marked as 'empty') is used in our design to mimic shorter lantibiotics (for example, epidermin and gallidermin) that lack a sequence connecting B2 to the P2 region. c, The different modules were shuffled by DNA synthesis, retaining the sequence B1-B2-P1-P2-P3, and the library of 6,000 variants was overexpressed in the PTM-competent secretion host L. lactis NZ9000 (pIL3BTC).
NaTure ChemiCal BiOlOgy prenisin-secreting cells and found that candidate strains secreting prenisin, but not a non-secreting control strain, efficiently inhibited the growth of the sensors (Fig. 2b and Supplementary Fig. 5 ). We also observed a higher sensitivity of the nanoFleming assay when compared to standard inhibition zone assays ( Supplementary  Fig. 6 ). This corroborated the suitability of the miniaturized assay for the identification of compounds in screening campaigns where production levels of the active substance might frequently be low.
Library screening and hit verification. Next, we screened the combinatorial peptide library using the nanoFleming platform (Fig. 2c) . Out of 3.2 × 10 5 nLRs, we isolated 839 nLRs (0.8%) containing very low levels of sensor biomass. The nLRs were spotted on agar plates and 617 of the embedded candidate strains (73.5%) could be regrown. We selected the 326 candidates that had shown the lowest green fluorescence in the screen for further processing.
The peptide-encoding DNA sequences of all isolated clones were determined and 205 unique peptide variants were characterized with respect to production level and antimicrobial activity. Each clone was grown in liquid culture, the secreted peptide was precipitated and the leader was fully cleaved with NisP sol . As only the sequence of the putatively antimicrobial core peptides but not the leader sequence varied, the production level and the fraction of correctly cleaved peptide could be estimated on the basis of the leader concentration by high-performance liquid chromatography-tandem mass spectrometry (HPLC-MSMS). Next, the activity of the mixture was analyzed with a conventional inhibition zone assay 28 against M. flavus ( Supplementary  Fig. 7 ) and a panel of model pathogens ( Supplementary Fig. 8 ).
The activity data as well as the production levels were compared to nisin as reference. From the group of 205 isolated clones, we identified 126 peptides that showed reproducible halo formation against M. flavus. On the basis of the DNA sequence data, heavily shuffled (modules from up to five different parents combined in a single peptide) as well as mildly shuffled antimicrobial peptides were generated. 
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Design guidelines for bioactive lanthipeptides. We next set out to identify guidelines for the design of bioactive molecules on the basis of the activity and secretion level of the 205 unique peptides obtained in the initial screen (126 positive, 79 negative). To ensure NisP cleavage, only two modules had been included for permutation at B1. Both were found in the screening hits and the corresponding peptides displayed considerable activity and production levels (Fig. 3) . At B2, the modules derived from gallidermin and nisin were clearly overrepresented in the fraction of the isolated peptides and seemed to facilitate processing and secretion as compared to the remaining four options. Furthermore, all peptides bearing these two modules had a rather high activity, possibly indicating efficient processing of the peptide by the NisBTC PTM machinery 17 . At P1, the structural variety found in the subset of efficiently produced peptides was much larger than at B2, and modules derived from actagardine, nisin, paenibacillin, pep5 and subtilin were found. Similarly, modules from actagardine, nisin and paenibacillin were found in active bacterial variants. For P2 (hinge region), all modules showed production (at variable mean levels) and were represented among bioactive peptides. Similar results were observed for P3: All five possible modules were among the population of analyzed peptides, but we again observed a clear overrepresentation of the nisin-derived module. Still, all modules tested for P3 were included in bioactive peptides. Taken together, 22 of the 33 modules that had been shuffled were identified afterward in newly generated bioactive peptides. These results indicate that antimicrobial lanthipeptides can be assembled by combinatorial recombination of peptide modules and that, despite a considerable variation of the amino acid sequence, most of these modules can become part of novel and bioactive peptides.
Minimal inhibitory concentrations against pathogens.
On the basis of their activity in the preliminary assays and their modular diversity, we selected 61 peptides for further characterization. To facilitate the purification of the peptides in large quantities, we integrated a His 6 -tag into the leader peptide. Modified precursor peptides were then purified via immobilized metal ion affinity chromatography (IMAC), the leader peptide was removed, and the core peptides were further purified by reversed-phase HPLC. For 31 peptides, this pipeline allowed purification of sufficient material to determine the minimal inhibitory concentration (MIC) against M. flavus and a panel of seven Gram-positive pathogenic strains, including Streptococcus pneumoniae, two methicillin resistant Staphylococcus aureus, vancomycin resistant Enterococcus faecalis, vancomycin resistant E. faecium and Bacillus cereus.
We observed a large MIC range of the purified peptides against the screening strain M. flavus, with many of the peptides exhibiting an MIC of <0.5 μg ml −1 (Supplementary Table 2 and Supplementary  Fig. 9 ). Furthermore, we identified peptides with improved activity against one or more of the pathogenic reference strains when compared to nisin and gallidermin (Table 1) . Nisin seems particularly active against both Enterococci and both Staphylococci strains and gallidermin against the two Streptococci strains. When combining the lipid II-binding moiety B1 and B2 of gallidermin with the pore-forming modules P1-P3 of nisin, the combinatorial peptide 1 showed improved activities against Streptococci when compared to nisin and improved activities against one of the two Staphylococci and the two Enterococci when compared to gallidermin. The similar variant peptide 2 with an additional module exchange in P2 showed even better activity against the two Staphylococci and one of the two Mean values were calculated from only those peptides that had advantageous modules at all other positions (green dots). b, As in a, but for relative production level. c, Fraction of the module in all isolated variants (n = 205). All peptides were precipitated in duplicate (n = 2), and antimicrobial activity and production levels were quantified in triplicate. Each dot represents the mean of those measurements.
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Enterococci. Certain module combinations also led to peptides with strongly reduced activities against a specific strain, but retained a high specific activity against others, suggesting a possible increase in selectivity. For example, peptide 3 displayed good bioactivity against most strains of the test panel but activity against one of the Enterococci was strongly reduced when compared to nisin or gallidermin (Table 1) .
Bypassing lantibiotic defense mechanisms. Two specific microbial defense mechanisms against nisin are characterized
29
. One is constituted by the nisin immunity machinery, which is present in nisin-producing strains. This is composed of the proteins NisI and NisFEG which prevent nisin binding to lipid II. The second mechanism is the nisin resistance protein (NSR) present in non-producing (pathogenic) strains. NSR works as a peptidase that cleaves the linear C terminus of nisin (last six amino acids) after the interwoven rings D and E and increases the MIC 20-fold. In the latter case, ring E is crucial for recognition 29, 30 . We have identified both peptides for which the natural nisin immunity system showed only reduced effectiveness by testing L. lactis NZ9803 expressing nisI and nis-FEG and comparing it to L. lactis NZ9000 not expressing the genes (Table 2a ) and for which a natural resistance determinant, the NSR from S. agalactiae, produced by L. lactis NZ9000 (pNSR), no longer showed any activity in comparison to L. lactis NZ9000 (pEmpty) not producing NSR (Table 2b) .
Inference of structural features. In addition to the bioactivity of these combinatorial peptides, we were interested in the degree of PTM introduced by NisB and NisC. We therefore analyzed the final set of 11 peptides with improved activity against the pathogenic reference strains (Table 1 ) and the ability to bypass defense mechanisms (Table 2 ) by mass spectrometry. As the main modification pattern for all peptides analyzed, we could identify a degree of dehydration of serine and threonine residues that is comparable to that of nisin (70 to 100%, nisin: 89%) and observed that all cysteines were involved in thioether ring formation except for peptide 7 (three of four cysteines involved) and peptide 10 (four of seven cysteines involved) (Supplementary Figs. 10 and 11). These results indicated the successful combinatorial design of novel lanthipeptides.
Discussion
Large-scale engineering of natural products is a promising strategy to obtain improved bioactive molecules but currently suffers from two bottlenecks: a lack of insight into the determinants of functional modularity in large enzyme clusters and a lack of efficient methods to Articles NaTure ChemiCal BiOlOgy explore the antimicrobial activity of large sets of variants at high speed. Here, we show that assays for antimicrobial activity can be efficiently downscaled and parallelized, making the latter bottleneck obsolete. By switching from natural products whose structure is encoded in the reaction specificity of enzymes to those that are gene-encoded, such as lantibiotics, we drastically facilitate the production of potentially active molecule variants. We do not entirely escape the boundaries of enzyme specificity with this approach, as enzyme-based PTMs remain important, but the availability of promiscuous PTM systems as well as the sheer number of variants that DNA manipulation can deliver in screens of the type demonstrated here, make the successful isolation of active, peptide-based natural products much more likely. We illustrate this by modular shuffling of lantibiotics, for which we could easily isolate 126 novel active antimicrobial peptides, some of them displaying improved or shifted activity profiles, by combining modules from other lantibiotics or of synthetic nature. The presented strategy is scalable without adaptation of the protocol by increasing the number of modules, and it can readily be adapted to other pathogenic hosts 31 as well as to other library generation methods. In this study, we focused on lipid II-binding peptides and the nisin modification machinery. However, the strategy is applicable to all antimicrobial peptides as long as they are secreted by the producing host. We envision that the use of more diverse peptide modules, including those exhibiting a different mode-ofaction, will enhance the diversity of the isolated bioactive peptides.
A bottleneck that cannot be entirely excluded is the substrate specificity of the PTM enzymes that limit the diversity of peptides that can be produced. However, given the capacity of the nanoFleming assay, future approaches might include various different PTM enzymes co-expressed in the production host or even include direct evolution on such enzyme to broaden their substrate specificity and therefore widen the diversity of the isolated antimicrobial peptides. When retaining the module shuffling strategy, the length of the antimicrobial peptides in the library is currently restricted by the capabilities of chemical DNA synthesis (roughly 150 bases), which is sufficient for many RiPP genes, but can be extended using oligosynthesis together with established assembly-strategies 32 . Also, the nanoFleming assay can be easily scaled to up to 1 × 10 6 clones per day, which is the current limit for large particle flow cytometry. In summary, the presented platform represents a powerful approach to the generation of topologically novel antimicrobial peptides.
In the future, this platform might not only be useful for the discovery of molecules with improved or altered bioactivity profiles but also for the generation of sufficient diversity required at other steps in drug development of peptides (for example, to test candidate peptides for plasma stability or activity in vivo). Last, we envision the nanoFleming platform could be of help also for addressing other questions in peptide development, such as for the improvement of peptide secretion from host strains by genetic engineering.
Online content
Any methods, additional references, Nature Research reporting summaries, source data, statements of data availability and associated accession codes are available at https://doi.org/10.1038/ s41589-019-0250-5. Supplementary Table 5 for a list of plasmids) was cultivated in 14 ml polypropylene tubes filled with M17 broth (Difco) supplemented with 5 g l −1 glucose (GM17 broth) and incubated at 30 °C without aeration. For screening and peptide production a chemically defined medium (CDM) was used. CDM contained 83.26 mM glucose, 150.00 mM 2-(N-morpholino)ethanesulfonic acid (MES)
mM l-alanine, 1.40 mM l-arginine, 0.61 mM l-asparagine, 1.03 mM laspartic acid, 0.35 mM l-cysteine, 0.66 mM l-glutamic acid, 0.66 mM l-glutamine, 0.39 mM glycine, 0.16 mM l-histidine, 0.63 mM l-isoleucine, 0.89 mM l-leucine, 1.02 mM l-lysine, 0.26 mM l-methionine, 0.39 mM l-phenylalanine, 3.58 mM lproline, 1.64 mM l-serine, 0.57 mM l-threonine, 0.18 mM l-tryptophan, 2.76 mM ltyrosine and 0.73 mM l-valine. Depending on the application, CDM medium was further supplemented: CDM-S (for nanoFleming screening) contained in addition 9.00 mM potassium phosphate and 7.04 mM calcium chloride and was adjusted to pH 6.5 with sodium hydroxide. CDM-V (for peptide precipitation) contained in addition 20.00 mM potassium phosphate, 20.00 μM calcium chloride and 10.00 g l −1 tryptone and was adjusted to pH 7.0. CDM-P (for peptide purification) contained in addition 20.00 mM potassium phosphate, 20.00 μM calcium chloride and 5.00 g l −1 tryptone, and was adjusted to pH 7.0. All media were supplemented with the appropriate antibiotics for plasmid maintenance: for E. coli, 20 μg ml −1 chloramphenicol, 250 μg ml −1 erythromycin and/or 50 μg ml −1 kanamycin; for L. lactis, 10 μg ml −1 chloramphenicol and/or 10 μg ml −1 erythromycin. M. flavus NIZO B423 was cultivated in LB-Miller broth and incubated at 30 °C with aeration. The indicator strains used in inhibition zone assays, S. aureus ATCC 29213 and ATCC 33591 were cultivated in cation adjusted Mueller-Hinton broth (MHB 2, Difco) and incubated at 37 °C with aeration. E. faecalis ATCC 29212 and ATCC 51575 were incubated in Todd-Hewitt broth (Difco) and incubated at 37 °C with aeration. S. pneumoniae ATCC 49619 was cultivated in Todd-Hewitt broth supplemented with 10% fetal bovine serum (P30-3302, Milian Analytica) and incubated at 37 °C without aeration. The strains used for MIC testing, S. aureus CAL and MW2, E. faecalis LMG 16216, E. faecium LMG 16003 and B. cereus ATCC 14579 were cultivated in MHB (Difco). S. pneumoniae TIGR-4 and D39 were cultivated in MHB supplemented with 5% defibrinated sheep blood (Oxoid, Thermo Fisher Scientific). The strain L. lactis NZ9803 displaying nisin immunity was based on L. lactis NZ9800 that was genome engineered to carry a deletion of the nisP gene using a method described previously 33 . Expression of the immunity cluster was induced by adding 5 ng ml −1 nisin (from a 1 mg ml −1 stock in 0.05% aqueous acetic acid) to the medium. Strain L. lactis NZ9000 (pNSR), producing the nisin resistance protein from a plasmid 30 was cultivated as described for NZ9000 but adding 5 ng ml −1 nisin and 10 μg ml −1 chloramphenicol to the medium to induce the expression of the nsr gene and maintain the plasmid, respectively. In case cultivations were done on solid medium, 15 g l −1 agar (Difco) was added to the broth.
Synthesis and cloning of the DNA library. The combinatorial peptide library was synthesized without the leader peptide sequence as DNA oligonucleotide representing the antisense strand and using solid phase synthesis (see Supplementary Fig. 2 ) by Ella Biotech. It was flanked by 5′ and 3′ primer binding site for second strand synthesis (see Supplementary Table 6 for the DNA oligonucleotide sequences of the modules). The second strand was synthesized in a primer extension reaction using the oligonucleotide mixture and the primer lib-2nd-fw in a 1:1 stoichiometric ratio (roughly 20 pmol each in 50 μl) together with 3 units of Phusion High-Fidelity DNA Polymerase (New England Biolabs) using standard PCR reaction conditions. The double stranded product was purified using Agencourt AMPure XP beads (Beckman Coulter) and cloned into plasmid pSEVA241-silent. The plasmid features transcriptional terminators 5′ and 3′ to the cloning site and it contains a ccdB expression cassette between NheI and HindIII cloning sites for efficient elimination of religands 34 . The plasmid was generated by amplifying the ccdB cassette using primers ccdB-BamHI-NheI-fw and ccdBHindIII-rv from plasmid pQL11 and then inserted into the multiple cloning site of pSEVA241. After plasmid proliferation in the CcdB resistant E. coli DB3.1 and Sanger-sequencing using primer pSEVA-t1-fw and pSEVA-t0-rv, the library DNA was cloned into pSEVA241-silent using E. coli DH5α. Growth of the transformants was done on large Petri dishes (145 mm diameter, Greiner) filled with 50 ml of LB-Miller agar and by plating roughly 1 × 10 4 colony forming units (c.f.u.s) per plate (ten plates in total, roughly equal to a 15-fold oversampling of the library). After incubation, the biomass was scraped off the plates and the plasmid library pSEVA241-library was isolated.
Next, the library was cloned into the screening plasmid pNZE3-rdm-mcherry. This plasmid was derived from plasmid pNZE3-nisA and served as shuttle for transfer of the library from E. coli to L. lactis. The plasmid was first modified to add the gene for the red fluorescent protein mCherry. The gene was PCR-amplified from the BioBrick part BBa_J06504 in plasmid pSB1C3 using primers mcherryNdeI-fw and mcherry-HindIII-BamHI-rv. Next, the constitutive promoter P23 (ref. 35 ) was PCR-amplified together with the RBS and the first 21 bases of the P23 regulated gene from the chromosome of L. lactis NZ9000 using primers P23-HindIII-NheI-fw and P23-NdeI-rv. Both PCR-products were digested with NdeI, ligated and the ligation-product was amplified using primers P23-HindIII-NheI-fw and mcherry-BamHI-rv, followed by a digest with NheI and BamHI. The same restriction sites were integrated into the plasmid pNZE3-nisA using enzymatic inverse PCR 36 and the primers pNZE3pNG-NheI-fw and pNZE3pNG-BamHI-rv, which also contained a BsaI restriction site on both ends to circularize the plasmid. Next, the promoter::mcherry fusion was cloned into that plasmid and the NheI site was removed using a modified QuickChange protocol 37 and primers mcherry-NheIrm-fw and mcherry-NheI-rm-rv to result in plasmid pNZE3-nisA-mcherry. Finally, the wild-type nisA expression cassette was replaced by the cassette nis-fragmentBglII-HindIII containing the nisin-inducible promoter P nis , the gene for the nisin leader peptide and the nisin structural gene (both genes were codon optimized for L. lactis MG1363) where a NheI restriction site was added between structural gene and the gene encoding for the leader peptide to facilitate the cloning of the leaderless library genes. The cassette was custom-synthesized (Geneart) and isolated from plasmid pMA-T-nisAopt by digesting with enzymes BglII and HindIII cloned into pNZE3-nisA-mcherry to result in plasmid pNZE3-nisAopt-mcherry. As a last step, the nisA structural gene was removed from that plasmid by digestion with NheI and HindIII and ligation of a random DNA fragment, assembled by the annealing of the oligonucleotides rdm-NheI-HindIII-fw and rdm-NheI-HindIII-rv and resulted in plasmid pNZE3-rdm-mcherry. All pNZ-based plasmids were Sanger-sequenced using primers pNZE3-seq-fw or pNZE3-seq-rv.
The library was then transferred from the pSEVA241-library to pNZE3-rdmmcherry via NheI and HindIII to obtain the plasmid library pNZE3-librarymcherry, which was then used to transform strain E. coli DH5α. The transformants were grown on large Petri dishes filled with 50 ml LB-Miller agar supplemented with the appropriate antibiotics and by plating roughly 5 × 10 6 c.f.u.s per plate (ten plates in total). The biomass was scraped off the plate and the plasmid was isolated. In the final step, the screening strain L. lactis NZ9000 (pIL3BTC) was transformed with the plasmid library to yield the candidate cells. The transformation mixture was again plated on large Petri dishes, this time filled with 50 ml GM17 agar, supplemented with the appropriate antibiotics and the cells were scraped off after growth for 48 h. The strain was diluted in liquid culture (GM17 broth, supplemented with appropriate antibiotics) to an optical density OD 600 of 0.5 and incubated at 30 °C for 3 h. The culture was then supplemented with glycerol to a volume fraction of 20%, 1 ml aliquots were frozen at −80 °C and the c.f.u.s of the stock were determined by plating.
Library quality control. The modular composition of the library was analyzed by next generation sequencing (Illumina MiSeq platform) at the following stages: (1) directly after second strand synthesis; (2) in plasmid pSEVA241-library after library cloning in E. coli; (3) in plasmid pNZE3-library-mcherry after library cloning in E. coli and (4) after transfer to L. lactis. The double-strand DNA fragment from stage I was directly used for sequencing. For stages 2, 3 and 4, the library fragment was isolated from the plasmids by NheI and HindIII digestion followed by purification with an agarose gel. The linear DNA fragments were processed as recommended by the MiSeq Reagent Kit and sequenced in a pairedend run with 251 cycles on a MiSeq device (Illumina) running RTA, v.1.18.54 (provided by the device manufacturer). Raw data were processed using the software bcl2fastq, v.2.18.0.12 (provided by the device manufacturer) and the resulting FASTQ files from each sequencing run were processed using an in house written software to identify module counts, sequence mismatches and indels. The resulting datasets were used to judge bias and error rate of each of the synthesis and cloning steps (see Supplementary Fig. 2 ). nanoFleming screening. Depending on the experiment, the candidate strain either carried a plasmid for secretion of prenisin (pNZE3-nisA-mcherry = positive control), an empty plasmid (pNZE3-rdm-mcherry = negative control) or the plasmid library (pNZE3-library-mcherry). As sensor strain, M. flavus (NIZO B423) or L. lactis NZ9000 (pNG-nisTP-tdgfp) was used. Encapsulation of cells into nLRs was done as previously described 24 using laminar-jet breakup (VAR D encapsulator from Nisco Engineering) of a sodium alginate solution (20 g l −1 alginate in water, sterile-filtered) and using bacterial glycerol stocks. C.f.u.s were adjusted such that on average each nLR contained 0.3 candidate cells and 150 sensor cells. The encapsulator was operated at 0.7 kHz with a flow rate of 3.3 ml min −1 and a nozzle diameter of 150 μm. Reactors were solidified in nLR hardening buffer (1 mM tris(hydroxymethyl)aminomethane hydrochloride (Tris-HCl) pH 7.0, 100 mM CaCl 2 ) for 20 min, and briefly rinsed with nLR wash buffer (1 mM Tris-HCl pH 7.0, 10 mM CaCl 2 ). The average nLR diameter after hardening was 460 μm (roughly 50 nl, column volume (CV): 4-7%). The nLRs where then transferred to CDM-S medium (100 g nLR l −1
) and incubated for 6 h at 30 °C on a shaker (200 r.p.m., 25 mm amplitude, Kuhner). The nutrients provided in this medium were not sufficient for growth of the sensor but allowed for growth of the candidate (candidate head start). After 6 h, the medium was supplemented with 5 ng ml −1 nisin to induce peptide production. After an additional hour of incubation, 10 g l
tryptone was added (from a 100 g l −1 stock in water) to allow for the growth of the sensor. Furthermore, the protease NisP sol was added (only if not already expressed by the sensor strain) at a final concentration of 0.2 μg ml −1 (from a 20 μg ml
enzyme stock in 100 mM MES buffer, pH 6.0). The nLRs were incubated for another hour and then removed from the medium using a cell strainer (100 μm mesh size, Falcon, Becton Dickinson) and an aliquot of roughly 1 g (wet weight, roughly 2 × 10 4 nLRs) was added to a 50 ml centrifugation tube prefilled with 45 ml of a hydrophobic phase (mineral oil heavy, Carl Roth), supplemented with surfactants (40 g l −1 Span80 and 10 g l −1 Tween85). Emulsification was achieved by vigorous shaking, the whole content of the tube was poured into a large Petri dish (145 mm diameter) and incubated at 30 °C for 18 h.
After incubation, the emulsion was transferred into a sterile glass beaker and the oil was decanted. The nLRs were then transferred to 50 ml centrifugation tubes (roughly 10 ml of wet nLRs per tube) and washed several times with nLR wash buffer supplemented with 0.1 g l −1 Tween20, followed by centrifugation (1,000g, 1 min) until all remaining oil was removed. The nLRs were then transferred to 50 ml of fresh nLR wash buffer and the biomass was stained (if not labeled by tdGFP) by the addition of 1 μM of SYTO 9 (from a 5 mM stock in DMSO, Thermo Fisher Scientific) followed by incubation in the dark for 1 h at room temperature at roughly 20 r.p.m. on a benchtop roller incubator.
The nLRs were then analyzed using a large particle flow cytometer (BioSorter, Union Biometrica) 23 . The device was operated with water as sheath fluid and analysis was done with extinction at 488 nm as a trigger signal and recording data for time-of-flight (as a relative estimate of the particle size), extinction at 488 nm, green fluorescence (sensor, excitation laser 488 nm, beam splitter DM 562, emission filter BP 510/23 nm) and red fluorescence (candidate, excitation laser 561 nm, TR mirror, emission filter BP 615/24 nm). Signal recording and selection of subpopulations was done using the Flow Pilot software, v.1.3.08 (provided by the device manufacturer). Data analysis was done using the FlowJo software, v.10.1 (FlowJo LLC). Before analysis of the library, samples containing nLR with embedded colonies of the positive control and negative control were analyzed. For library screening, nLRs displaying low green fluorescence intensity levels (lower than the mean green intensity of the negative control by at least 3 σ) were sorted into a 50 ml centrifugation tube prefilled with 10 ml nLR wash buffer (device specific 'enrichment mode' , max. 150 Hz sorting rate). Then, isolated nLRs were subjected to another sorting ('pure mode' , maximum 1 Hz sorting rate), this time spotted into Nunc MicroWell 96-well plates (no. 167008, Thermo Fisher Scientific) filled with 100 μl of GM17 broth that was supplemented with 10 μg ml −1 chloramphenicol and 10 μg ml −1 erythromycin to allow for selective recovery of the candidate strain while killing the sensor strain. The plates were sealed (airtight aluminum foil) and incubated at 30 °C for 72 h without shaking to expand the candidate strain from the nLR. Cultures in the wells were then supplemented with glycerol to a final volume fraction of 20%, the plates were sealed and frozen at −80 °C.
Fluorescence microscopy. Microscopic analysis of nLRs was carried out with the inverted fluorescence microscope Axio Observer II equipped with an AxioCam MR3 camera (Carl Zeiss Microscopy) either using bright-field or epifluorescence with filter cubes (for GFP, SYTO 9: excitation BP 470/40 nm, beam splitter DM 495 nm, emission BP 525/50 nm; for mCherry: excitation BP 565/30 nm, beam splitter DM 585 nm, emission BP 620/60 nm). Images were taken using the AxioVision software, v.4.8.2 SP3 (provided by the device manufacturer). If brightfield and epifluorescence were recorded from the same object, images were stored as overlays of both channels. Image processing and analysis was done using the Fiji software 38, 39 .
Peptide identification and precipitation. For each peptide, a culture in 10 ml GM17 broth inoculated from a single colony of the peptide producing strain was prepared. After growth, 6 ml of the culture was used to isolate the plasmid and the peptide gene was Sanger-sequenced using primer pNZE3-seq-fw. Next, the peptide was precipitated by trichloroacetic acid 40 . For this, 90 ml of CDM-V medium supplemented with the appropriate antibiotics and 5 ng ml −1 nisin was inoculated with 900 μl from the GM17 culture. After 24 h of incubation, the cells were pelleted by centrifugation (3,200g, 30 min) . The peptide was precipitated by adding 10 ml of an ice-cold, saturated trichloroacetic acid solution (in water) to the supernatant and freezing (−20 °C) the mixture for >2 h. After thawing, the precipitated peptide was pelleted by centrifugation (48,000g, 30 min, 4 °C) and washed once with icecold acetone followed by a second centrifugation. The pellet was dried at room temperature and resuspended in 1 ml of an 0.05% aqueous acetic acid solution. Next, the leader peptide was cleaved off using 750 μl of the peptide solution, 250 μl of 4× NisP cleavage buffer and NisP sol at a final concentration of 0.2 μg ml −1 (from a 20 μg ml −1 enzyme stock). The mixture was incubated at 37 °C until complete cleavage was achieved (roughly 36 h, monitored by HPLC-MSMS, see below). Each peptide was precipitated in duplicate.
Leader peptide quantification. The amount of leader peptide in the NisP sol treated peptide samples was quantified by HPLC-MSMS using an Agilent 1200 series HPLC system coupled to an Ab Sciex 4000 QTRAP triple quadrupole mass spectrometer (operated with Analyst software, v.1.6.3, Ab Sciex) and using electrospray ionization (ESI). An aliquot of 3 μl of the peptide sample was injected onto a RP-C18 column (ReproSil-Pur Basic C18 3 μm, 50 mm × 3 mm, Dr. Maisch), heated to 30 °C and operated with water supplemented with 0.1% formic acid as solvent A and acetonitrile supplemented with 0.1% formic acid as solvent B (all solvents mass-spectrometry grade). The column was equilibrated at 10% solvent B before injection. After injection, a gradient was imposed from 10% solvent B to 35% solvent B in 180 s at a flow rate of 800 μl min −1 . The column was washed with 95% solvent B for 45 s at 1,500 μl min −1 and equilibrated with 10% solvent B for 60 s at 1,500 μl min
. Usually, three leader peptide peaks were observed: peptide 1, without methionine, resulting from cleavage by endogenous methionine aminopeptidases; peptide 2, with a non-formylated methionine at the N terminus and peptide 3, with a formylated methionine at the N terminus. For quantification of the leader peptides, the mass spectrometer was operated in multiple reaction monitoring mode. The parameters for the TurboIonSpray probe: ion spray voltage (IS): 5,000 V, positive polarity, temperature (TEM): 700 °C, curtain gas (CUR): 20 psig, ion source gas 1 (GS1): 70 psig, ion source gas 2 (GS2): 60 psig, interface heater Inhibition zone assay. The antimicrobial activities of the precipitated peptides were confirmed using an inhibition zone assay 28 . The strains M. flavus (NIZO B423), S. aureus MSSA (ATCC 29213) and MRSA (ATCC 33591), E. faecalis VSE (ATCC 29212) and VRE (ATCC 51575) and S. pneumoniae (ATCC 49619) were used as sensor strains. Plates were assembled using 50 ml of the strain-specific agar, cooled to 40 °C and mixed with 2 ml of a culture at an OD 600 of roughly 1. The mixture was poured into large Petri dishes (145 mm diameter) and cooled to room temperature. Using a stamp, 19 holes (3 mm diameter) were inserted into the agar and 50 μl of the samples were pipetted into each hole. Plates were incubated for 24 h and imaged using a flatbed scanner. Zone areas were measured using the Fiji software 38, 39 . Inhibition zone areas were normalized to areas that resulted from a precipitated nisin control (relative quantification). Measurements were performed in triplicate.
Peptide production and purification. The leader peptide of each variant was equipped with a His 6 -tag followed by an additional tryptophan (HW-tag, see Supplementary Table 7 for DNA and peptide sequences). The tag was integrated by enzymatic inverse PCR using primers tag-HisW-BsaI-fw and tag-HisW-BsaI-rv, the product was cleaved with BsaI and re-circularized by ligation. The mix was used to transform L. lactis NZ9000 (pIL3BTC). The integration of the tag was confirmed by Sanger-sequencing using primer pNZE3-seq-fw.
For peptide purification, a 25 ml CDM-P preculture, supplemented with the appropriate antibiotics, of the peptide producing strain was incubated overnight. Then, 20 ml of the culture was used to inoculate 2 l of CDM-P medium supplemented with the same antibiotics and 10 ng ml −1 nisin. The culture was incubated without shaking until it reached stationary phase (after 24-36 h). After incubation, the cells were pelleted by centrifugation (6,000g, 30 min). The pH of the supernatant was adjusted to 7.0, filtered through a bottle-top filter (0.22 μm pore size, polyethersulfone membrane, Stericup, Merck Millipore) and stored at 4 °C. The pellet was resuspended in 50 ml of 70% isopropanol, 0.4% trifluoroacetic acid (TFA) and stirred at room temperature for 2 h to separate cell-bound peptides from pellet components. After centrifugation (3,200g , 10 min), the cell pellet was discarded and the isopropanol in the supernatant was removed with a rotary evaporator at 40 °C and 40 mbar for 10 min. The pH of the remaining solution was adjusted to 7.0 with NaOH and added to the previously retained supernatant for further treatment on an ÄKTAexplorer chromatography system (operated with Unicorn software v.5.31, GE Healthcare). The system was connected to a Ni-Sepharose EXCEL column (XK 16/20, 10 ml bed volume, GE Healthcare) equilibrated with five column volumes of IMAC equilibration buffer. The culture supernatant was loaded onto the column at a flow rate of 10 ml min −1
. The column was washed with 10 CV of IMAC equilibration buffer. The peptides were eluted with 3 CV of IMAC elution buffer I followed by 3 CV of IMAC elution buffer II. The whole elution fraction (60 ml) was collected and then loaded onto a Sephadex G-15 column (XK 50/30, 300 ml bed volume) for desalting that was equilibrated with 5 CV of desalting buffer pH 4.0 (100 mM ammonium acetate/ acetic acid buffer, pH 4). The same buffer was used for elution. The elution fraction corresponding to the peptide (monitored at 280 nm absorbance) was collected (roughly 100 ml), frozen at −80 °C for >2 h and lyophilized (roughly 60 h) using a freeze-dryer (Alpha 1-2 LDplus, Christ) connected to a vacuum pump (RC6, Vacuubrand).
To remove the leader peptide, the freeze-dried peptides were dissolved in 40 ml of NisP cleavage buffer containing NisP sol at a concentration of 0.2 μg ml −1 and incubated at 37 °C for 16 h. Cleavage of the leader peptide was monitored by HPLC (see below). When incomplete, more NisP sol was added. For HPLC analysis, an aliquot of 3 μl of the peptide was injected onto an RP-C18 column (ReproSil-Pur 120 C18-AQ 3 μm, 150 mm × 2 mm, 5 mm × 2 mm precolumn, Dr. Maisch) heated to 30 °C and operated at a flow rate of 300 μl min −1 with water supplemented with 0.1% TFA as solvent A and acetonitrile supplemented with 0.1% TFA as solvent B (all solvents mass-spectrometry grade). The column was equilibrated with 20% solvent B before injection. After injection and an initial wash step of 2.8 min a gradient was imposed from 20% solvent B to 50% solvent B in 16 min. The column was washed with 95% solvent B for 5 min and equilibrated with 20% solvent B for 9.2 min. Peptide elution was monitored at an absorbance of 205, 254 and 280 nm.
HPLC purification of the cleaved peptides was performed on an ÄKTAexplorer chromatography system. The complete peptide sample was injected onto a RP-C18 column (PRONTOSIL 120 C18 10 μm, 250 mm × 20 mm, 50 mm × 20 mm precolumn, Bischoff), heated to 30 °C and operated at a flow rate of 10 ml min -1 and with water supplemented with 0.1% TFA as solvent A and acetonitrile supplemented with 0.1% TFA as solvent B. The column was equilibrated with 20% solvent B before injection. After injection and an initial wash step of 6 min a gradient was imposed from 20% solvent B to 50% solvent B in 40 min. The column was washed with 95% solvent B for 8 min and equilibrated with 20% solvent B for 13 min. Peptide elution was monitored at an absorbance of 205 nm and peptide peaks were collected. The fractions were frozen at −80 °C for >2 h and lyophilized (roughly 18 h) using a freeze-dryer (Alpha 2-4 LDplus, Christ), connected to a vacuum pump (RC6, Vacuubrand). In the case where a peptide resulted in several peaks (for example, due to different PTM patterns of the same translation product), all peaks were MIC-tested (see below) but only the peak with the highest activity was processed further.
NisP production. The protease was secreted as soluble form (NisP sol ) where the cell wall anchor of the enzyme was replaced by a His 8 -tag and expressed from plasmid pNZ-nisP sol -8H. For production, a 10 ml GM17 preculture, supplemented with the appropriate antibiotic, of the strain was used to inoculate a 1 l production culture in GM17 broth, supplemented with the same antibiotic. At an OD 600 of 0.7, 5 ng ml −1 nisin was added and incubation was continued for 18 h and the culture was processed as described for the peptide purification. Purification was done on an ÄKTAexplorer chromatography system and using a Sepharose 6 Fast Flow column (GE Healthcare), loaded with Co 2+ ions (XK 16/20, 10 ml bed volume) equilibrated with 5 CV of IMAC equilibration buffer. The supernatant was loaded onto the column at a flow rate of 5 ml min −1
. The column was washed with 10 CV of IMAC equilibration buffer. The protein was eluted with 6 CV of elution buffer II and fractions containing NisP sol were pooled (roughly 30 ml) and then loaded onto a Sephadex G-15 column (XK 50/30, 300 ml bed volume) for desalting using a buffer containing 100 mM MES at pH 6.5. Next, glycerol was added to a final volume fraction of 10%, the protein amount was adjusted to 20 μg ml −1 and the protease was frozen at −80 °C.
If NisP was produced as variant bound to the cell wall (for example, for L. lactis as sensor strain), plasmid pNG-nisTP-gfp was used. The plasmid was based on pNG-nisTP that was modified to carry the gene for tdGFP. The modification was done as described for pNZE3-nisA-mcherry using primers pNZE3pNG-NheI-fw and pNZE3pNG-BamHI-rv for enzymatic inverse PCR and cloning the gene for tdGFP from plasmid pKQV5-tdgfp using primers tdgfpNdeI-fw and tdgfp-HindIII-BamHI-rv.
Measurement of MICs.
For MIC measurements, the HPLC-purified and lyophilized peptides were resuspended in 1 ml of an 0.05% aqueous acetic acid solution and analyzed by HPLC as described above. The concentration was measured using the area under the curve at 205 nm and peptide-specific absorption properties 41, 42 . For MIC assays, the bacteria were grown overnight on strain-specific agar plates. The peptides were diluted with 0.05% acetic acid to a concentration of 128 to 1,024 μg ml −1 (depending on the strain tested). The exact amount of peptide in the dilution was again quantified via HPLC. MICs were measured as microdilution assay in 96-well flat bottom polypropylene plates (Greiner) and performed as described by Wiegand et al. 43 . The plates were sealed (airtight aluminum foil) and incubated for 18 h without shaking at the strain-specific temperature before reading the OD 600 using an Infinite Pro F200 plate reader (Tecan). The MIC value was set as the minimal concentration where no growth of the bacterial strain was observed (<5% of the OD 600 value of the positive growth control in column 11). MIC experiments were performed in triplicate.
Mass-spectrometric characterization of peptides. Each peptide was analyzed twice, first to determine the number of dehydrations and second to quantify the sulfhydryl groups. The difference between the two was then used to elucidate the number of thioether rings that must have been formed. Dehydrations were characterized by mass shifts of −18 Da, sulfhydryls were measured indirectly by derivatization of those groups with 1-cyano-4-dimethylaminopyridinium tetrafluoroborate (CDAP) resulting in a mass shift of +25 Da. For analysis, the HPLC-purified and lyophilized peptides were resuspended in 0.05% aqueous acetic acid to reach a concentration of 1 to 5 mg ml −1 . Next, 25 μl of the peptide was mixed with 1 μl of a 500 mM tris(2-carboxyethyl)phosphine solution (in water, freshly prepared) in HPLC glass vials (>ten-fold molar excess of tris(2-carboxyethyl)phosphine solution) and incubated for 10 min at room temperature. For quantification of dehydrations, 24 μl of an 0.05% aqueous acetic acid solution was added and the sample was immediately measured. For quantification of sulfhydryls, 24 μl of a 178 mM CDAP (in 0.05% aqueous acetic acid, freshly prepared) was added (>100-fold molar excess of CDAP) and incubated for 30 min at room temperature before measurement.
Measurements were taken using an Agilent 1200 series HPLC system coupled to an Ab Sciex 4000 QTRAP triple quadrupole mass spectrometer and using electrospray ionization. The device was calibrated before measurement using the MS Chemical Kit 1, Low-High Conc. PPGs (Ab Sciex, 4406127) according to the manufacturer's recommendation. An aliquot of 2 μl of the sample was injected onto an RP-C18 column (ReproSil-Pur 120 C18-AQ 3 μm, 150 mm × 2 mm, 5 mm × 2 mm precolumn, Dr. Maisch) heated to 30 °C. The HPLC parameters were the same as for the peptide quantification (see above) but using formic acid instead of TFA. The mass spectrometer was operated in Q1 mode. The parameters for the TurboIonSpray probe were: ion spray voltage (IS): 5,000 V, positive polarity, temperature (TEM): 300 °C, curtain gas (CUR): 20 psig, ion source gas 1 (GS1): 70 psig, ion source gas 2 (GS2): 60 psig, interface heater (ihe): ON and the settings for the MS: declustering potential (DP): 60 V, entrance potential (EP): 10 V, collision cell rod offset (RO2): −60 V, Q3 rod offset (RO3): −62 V and exit lens (EX): −75 V.
Each sample was analyzed twice, a first explorative scan from 500 to 2,000 m/z at a scan rate of 1,000 Da s −1 was followed by a precise scan covering a window of 100 m/z at a scan rate of 250 Da s −1 for a maximum of three charge states. The data was processed using a script written in the programming language R and employing the MALDIquant package 44 . The data was deconvoluted, averaged and centroided (signal-to-noise threshold, 5%). The results where then compared to the calculated peptide masses 41 to determine the number of dehydrations or sulfhydryl groups.
Statistical analysis. For nanoFleming screening, statistical parameters consisted of the absolute number of nLRs analyzed, the numbers of nLRs in the low and high green fluorescence subpopulations as well as the mean green fluorescence, its standard derivation and coefficient of variation. All parameters were calculated using the Flow Pilot software (v.1.3.08, Union Biometrica) directly during screening. For MIC measurements, only those experiments were considered as reproducible where the spread of the three MIC values defined as log 2 (MIC max − MIC min ) was ≤2. The statistical evaluation of the MIC values was done with a script written in the programming language R.
Reporting Summary. Further information on research design is available in the Nature Research Reporting Summary linked to this article.
Data availability
The raw data from next generation sequencing of the peptide-encoding DNA libraries in Supplementary Fig. 2 are available in the NCBI Sequence Read Archive (SRA), accession number PRJNA511380.
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Data analysis
Large-particle flow cytometry data were analyzed using FlowJo (FlowJo LLC), version 10.1 Next-generation data were analyzed using bcl2fastq (Illumina), version 2.18.0.12 and a customized script written in the programming language R (available upon request) Mass spectrometry data were analyzed using Analyst (Ab Sciex), version 1.6.3 and a customized script written in the programming language R (available upon request) MIC data were analyzed using a customized script written in the programming language R (available upon request) Microscopy data were analyzed using Fiji All other data were analyzed using Excel (Microsoft), version 2016
For manuscripts utilizing custom algorithms or software that are central to the research but not yet described in published literature, software must be made available to editors/reviewers upon request. We strongly encourage code deposition in a community repository (e.g. GitHub). See the Nature Research guidelines for submitting code & software for further information.
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The raw data from next generation sequencing of the peptide encoding DNA libraries in Supplementary Figure 2 are available in the NCBI Sequence Read Archive (SRA), accession number: PRJNA511380 (https://www.ncbi.nlm.nih.gov/sra/PRJNA511380).
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Methodology Sample preparation
Large-particle flow cytometry was used for nanoliter reactor (nLR) analysis. Cell preparation methods are not required. Methods for nLR preparation prior analysis are listed in the Online Methods. Cell population abundance Not applicable for nLR analysis in large-particle flow cytometry. All nLRs were analyzed and correspond to 100% of the recorded events.
Gating strategy FSC/SSC is not applicable for nLR analysis in large-particle flow cytometry. All nLRs were analyzed without preselection by gating. The gating strategy for the isolation of hits is shown in Figure 2 .
Tick this box to confirm that a figure exemplifying the gating strategy is provided in the Supplementary Information.
